IL132999A0 - Process for making flurbiprofen lozenges - Google Patents

Process for making flurbiprofen lozenges

Info

Publication number
IL132999A0
IL132999A0 IL13299998A IL13299998A IL132999A0 IL 132999 A0 IL132999 A0 IL 132999A0 IL 13299998 A IL13299998 A IL 13299998A IL 13299998 A IL13299998 A IL 13299998A IL 132999 A0 IL132999 A0 IL 132999A0
Authority
IL
Israel
Prior art keywords
making
lozenges
flurbiprofen lozenges
making flurbiprofen
flurbiprofen
Prior art date
Application number
IL13299998A
Other languages
English (en)
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of IL132999A0 publication Critical patent/IL132999A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL13299998A 1997-05-22 1998-05-20 Process for making flurbiprofen lozenges IL132999A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9710521.7A GB9710521D0 (en) 1997-05-22 1997-05-22 Process
PCT/EP1998/003167 WO1998052539A1 (en) 1997-05-22 1998-05-20 Process for making flurbiprofen lozenges

Publications (1)

Publication Number Publication Date
IL132999A0 true IL132999A0 (en) 2001-03-19

Family

ID=10812840

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13299998A IL132999A0 (en) 1997-05-22 1998-05-20 Process for making flurbiprofen lozenges

Country Status (31)

Country Link
US (1) US6194003B1 (cs)
EP (1) EP0983059B1 (cs)
JP (1) JP2001527567A (cs)
KR (1) KR20010012739A (cs)
CN (1) CN1154480C (cs)
AR (1) AR015812A1 (cs)
AT (1) ATE245021T1 (cs)
AU (1) AU725760B2 (cs)
BG (1) BG103881A (cs)
BR (1) BR9809651A (cs)
CA (1) CA2290830C (cs)
CZ (1) CZ290816B6 (cs)
DE (1) DE69816440T2 (cs)
DK (1) DK0983059T3 (cs)
ES (1) ES2202871T3 (cs)
GB (1) GB9710521D0 (cs)
HU (1) HU224954B1 (cs)
ID (1) ID22949A (cs)
IL (1) IL132999A0 (cs)
IN (1) IN187837B (cs)
MY (1) MY118410A (cs)
NO (1) NO995681L (cs)
NZ (1) NZ500664A (cs)
PL (1) PL190947B1 (cs)
PT (1) PT983059E (cs)
RU (1) RU2203046C2 (cs)
SK (1) SK283701B6 (cs)
TR (1) TR199902725T2 (cs)
UA (1) UA53714C2 (cs)
WO (1) WO1998052539A1 (cs)
ZA (1) ZA984260B (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4040878B2 (ja) 1999-12-09 2008-01-30 レキット ベンキーザー ヘルスケア （ユーケイ） リミテッド 治療薬
AU2001257022B2 (en) * 2000-04-13 2005-02-03 Mayo Foundation For Medical Education And Research Abeta 42 lowering agents
JP4886107B2 (ja) * 2000-10-13 2012-02-29 サンスター株式会社 歯周病予防用口腔内溶解錠
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc COMPOSITION AND METHOD FOR TREATING NEURODEGENERATIVE DISORDERS
AU2004311577A1 (en) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
FR2865648B1 (fr) * 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
US20070293538A1 (en) * 2004-04-13 2007-12-20 Myriad Genetics, Incorporated Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
MXPA06012165A (es) * 2004-04-29 2007-01-17 Keystone Retaining Wall System Chapas para muros, muros de contencion y similares.
WO2006020853A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
AU2006211023B2 (en) 2005-02-03 2012-05-24 Takeda Nycomed As Fast wet-massing method for the preparation of calcium-containing compositions
GB2423710A (en) 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
KR20080039876A (ko) * 2005-07-22 2008-05-07 미리어드 제네틱스, 인크. 높은 약물 충진 제형 및 투여형
JP2009514857A (ja) * 2005-11-02 2009-04-09 テイコク ファーマ ユーエスエー インコーポレーテッド 感覚器官的に許容されるイブプロフェン経口投与用製剤、該製剤の製法並びに使用法
WO2008006099A2 (en) * 2006-07-07 2008-01-10 Myriad Genetics, Inc. Treatment of psychiatric disorders
US20090028802A1 (en) * 2007-07-23 2009-01-29 Toru Hibi Organoleptically acceptable indole serotonin receptor agonist oral dosage formulations and methods of using the same
CA2733180A1 (en) * 2008-08-22 2010-02-25 Reckitt Benckiser Healthcare (Uk) Limited Improvements in or relating to compositions
IT1397132B1 (it) 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
IT1406107B1 (it) * 2010-12-13 2014-02-14 Alfa Wassermann Spa Composizioni solide comprendenti antiinfiammatori non steroidei, processi per la loro preparazione e loro uso.
EP3173069A1 (en) 2011-04-29 2017-05-31 Moberg Pharma AB Pharmaceutical compositions comprising a local anaesthetic such as bupivacaine for local administration to the mouth or throat
EP2609911A1 (en) * 2011-12-29 2013-07-03 Sanovel Ilac Sanayi ve Ticaret A.S. A novel process for preparing orally disintegrating flurbiprofen formulations
FR2997856B1 (fr) * 2012-11-14 2015-04-24 Pf Medicament Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
JP6315741B2 (ja) * 2015-08-18 2018-04-25 合同会社Ｐｈａｒｍａ Ｓｅｅｄｓ Ｃｒｅａｔｅ ＮＳＡＩＤｓまたはヘパリン類含有口腔用組成物
WO2020013781A2 (en) * 2018-03-27 2020-01-16 Pisak Mehmet Nevzat Synergistic effect of flurbiprofen and a gastro protective agent for the treatment of pain and inflammation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4666716A (en) * 1984-09-04 1987-05-19 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
US5302394A (en) 1992-07-14 1994-04-12 Mcneil-Ppc, Inc. Dextromethorphan continuous lozenge manufacturing process
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
US5614207A (en) * 1995-06-30 1997-03-25 Mcneil-Ppc, Inc. Dry mouth lozenge
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment

Also Published As

Publication number Publication date
MY118410A (en) 2004-10-30
IN187837B (cs) 2002-06-29
DE69816440T2 (de) 2004-05-13
SK283701B6 (sk) 2003-12-02
NO995681D0 (no) 1999-11-19
NO995681L (no) 1999-11-19
PL190947B1 (pl) 2006-02-28
JP2001527567A (ja) 2001-12-25
WO1998052539A1 (en) 1998-11-26
PL336624A1 (en) 2000-07-03
AU725760B2 (en) 2000-10-19
EP0983059B1 (en) 2003-07-16
CN1255848A (zh) 2000-06-07
CA2290830C (en) 2006-07-11
CN1154480C (zh) 2004-06-23
PT983059E (pt) 2003-11-28
HUP0002121A2 (hu) 2000-12-28
ID22949A (id) 1999-12-16
HU224954B1 (en) 2006-04-28
CZ412099A3 (cs) 2000-02-16
BR9809651A (pt) 2000-07-11
NZ500664A (en) 2001-01-26
EP0983059A1 (en) 2000-03-08
US6194003B1 (en) 2001-02-27
DK0983059T3 (da) 2003-11-03
TR199902725T2 (xx) 2000-02-21
ES2202871T3 (es) 2004-04-01
DE69816440D1 (de) 2003-08-21
SK158899A3 (en) 2000-05-16
CZ290816B6 (cs) 2002-10-16
RU2203046C2 (ru) 2003-04-27
KR20010012739A (ko) 2001-02-26
AU7916598A (en) 1998-12-11
ATE245021T1 (de) 2003-08-15
AR015812A1 (es) 2001-05-30
HUP0002121A3 (en) 2001-04-28
GB9710521D0 (en) 1997-07-16
ZA984260B (en) 1999-02-20
BG103881A (en) 2000-05-31
UA53714C2 (uk) 2003-02-17
CA2290830A1 (en) 1998-11-26

Similar Documents

Publication Publication Date Title
IL132999A0 (en) Process for making flurbiprofen lozenges
GB9723295D0 (en) Novel process
GB9719426D0 (en) Novel process
EP0986389A4 (en) NEW PROCESS
HUP9904325A3 (en) Process for johexol manufacture
IL122454A (en) Process for forming bubble-pack
GB9700690D0 (en) Novel process
HUP0002522A3 (en) Process for making benzisothiazolin-3-ones
ZA983174B (en) Novel process
EP0990658A4 (en) PROCESS FOR PRODUCING TRIHYDROCARBYLALUMINUMS
MD810F1 (en) Process for modified ionites obtaining
HUP9903692A3 (en) Process for making dihydropyrimidinones
GB9505179D0 (en) Process for fluoroaromatics
GB9806533D0 (en) Novel process
GB9714012D0 (en) Novel process
GB9702477D0 (en) Novel process
GB9722905D0 (en) Novel process
GB9714875D0 (en) Novel process
GB9714049D0 (en) Novel process
GB9702541D0 (en) Novel process
GB9716566D0 (en) Novel process
GB9702553D0 (en) Novel process
GB9720567D0 (en) Novel process
GB9718700D0 (en) Novel process
GB9700691D0 (en) Novel process

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees